Sponsor:
Massachusetts General Hospital
Code:
NCT02118922
Conditions
Keratoconus
Ectasia
Crosslinking
Fuchs' Endothelial Dystrophy
Eligibility Criteria
Sex: All
Age: 20 - 70+
Healthy Volunteers: Accepted
Interventions
Brillouin imaging
Brief summary:
Conditions
Keratoconus
Ectasia
Crosslinking
Fuchs' Endothelial Dystrophy
Study ID
NCT02118922
Start date
Jun, 2013
Status verified date
Nov, 2025
Completion date
Sep, 2026
Anticipated
Primary completion date
Sep, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 20 - 70+
Healthy Volunteers: Accepted
Enrollment
168 participants
Anticipated
Arms
Healthy volunteers
Patients with keratoconus
post-LASIK no complications
post-LASIK who developed ectasia
Volunteers to receive PRK surgery
Volunteers to receive LASIK Surgery
Patients with Fuch's Endothelial Corneal Dystrophy
Interventions
Brillouin imaging
Primary outcome measure
Central contacts
Andy Yun, PhD
syun@partners.orgLocations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Sponsor
Massachusetts General Hospital
Last update posted
Nov 6, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-11-06.